Vivo Capital, LLC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 81 filers reported holding DESIGN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$6,672,000
-13.3%
476,5890.0%0.67%
+26.4%
Q1 2022$7,697,000
-32.3%
476,589
-10.2%
0.53%
-22.7%
Q4 2021$11,369,000
+45.8%
530,9910.0%0.69%
+96.0%
Q3 2021$7,800,000
-26.1%
530,9910.0%0.35%
-23.4%
Q2 2021$10,561,000
-33.5%
530,9910.0%0.46%
-18.1%
Q1 2021$15,877,000530,9910.56%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders